CHANGE MY LOCATION
Business and Finance
Business News
Employers cut 533K jobs in Nov., most in 34 years- Skittish employers slashed 533,000 jobs in November, the most in 34 years, catapulting the unemployment rate to 6.7 percent, dramatic proof the country is careening deeper into recession.
- News of a rapidly weakening job market is sending stocks lower in early trading.
Thailand reopens main international airport- Dancers, drummers and apologetic tourism officials greeted travelers Friday at the official reopening of Thailand's main international airport, which was shut down for a week by anti-government protesters.
US general spells out Iraq mission under new pact- A security pact that sets a timetable for troops to leave Iraq requires a shift in how the U.S. carries out combat missions during its remaining time in the country, the top U.S. military commander in Iraq said Friday.
- Stock intended to eventually earn taxpayers a profit as part of the Bush administration's massive bank bailout has lost a third of its value - about $9 billion - in barely one month, according to an Associated Press analysis. Shares in virtually every bank that received federal money have remained below the prices the government negotiated.
Hill leader says jobs report argues for car rescue- The chairman of the House Financial Services Committee says the new bleak unemployment figures makes helping the nation's beleaguered auto industry even more urgent.
- Barack Obama, who rewrote the book on presidential fundraising, amassed more than $745 million during his marathon campaign, more than twice the amount obtained by his rival, Republican John McCain.
AP Enterprise: Deaths loom over self-defense laws- A convenience store clerk chased down a man and shot him dead over a case of beer this summer and was charged with murder. A week later, a clerk at another Jackson convenience store followed and fatally shot a man he said tried to rob him, and authorities let him go without charges.
- Paul Benedict, the actor who played the English neighbor Harry Bentley on the sitcom "The Jeffersons," has died. He was 70.
Giants' Pierce to meet with NYC investigators- Antonio Pierce is finally going to talk to investigators about what he did on the night Plaxico Burress shot himself.
Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
PRINCETON, N.J.
(Map)
-
-- Novo Nordisk increased sales by 14% in local currencies and by 9% in
Danish kroner due to a significant negative currency development.
-- Sales of modern insulins increased by 37% (31% in Danish kroner).
-- Sales of NovoSeven(R) increased by 10% (4% in Danish kroner).
-- Sales of Norditropin(R) increased by 12% (7% in Danish kroner).
-- Sales in North America increased by 25% (15% in Danish kroner).
-- Gross margin increased to 76.7% in the first nine months of 2007 up
from 75.2% in the same period last year, primarily reflecting continued
productivity improvements.
-- Operating profit increased by 11% to USD 1,410 million. Adjusted for
the impact from currencies, underlying operating profit increased by
more than 20%.
-- Net profit increased by 60% to USD 1,361 million, primarily reflecting
the divestment of Dako's business activities in the second quarter of
2007. Earnings per share (diluted) increased by 62% to USD 4.26.
-- The expectation for full-year sales growth is still 11-14% measured in
local currencies and now 6-9% as reported due to the depreciation of
key invoicing currencies. Full-year operating profit growth remains
unchanged around 20% measured in local currencies and is now expected
to be close to 10% as reported.
-- In October, Novo Nordisk received marketing authorization for
Levemir(R) in Japan for both type 1 and type 2 diabetes including
combination treatment with oral antidiabetics.
Lars Rebien Sorensen, president and CEO, said "Our portfolio of modern
insulins continues to show strong sales growth in all key markets. Within the
next few months we will be launching Levemir(R) in FlexPen(R) in
* For convenience, Danish kroner has been translated to USD in this
release, using the average exchange rate of
Novo Nordisk is a healthcare company with an 84-year history of innovation
and achievement in diabetes care. The company has the broadest diabetes
product portfolio in the industry, including the most advanced products within
the area of insulin delivery systems.In addition to diabetes care, Novo
Nordisk has a leading position within areas such as hemostasis management,
growth hormone therapy, and hormone therapy for women. Novo Nordisk's business
is driven by the Triple Bottom Line: a commitment to economic success,
environmental soundness, and social responsibility to employees and customers.
With headquarters in
|
|
